Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Ronald A Morena
Introduction
Ronald A Morena is a notable inventor based in El Cajon, CA (US). He has made significant contributions to the field of therapeutic antibodies, particularly through his innovative patent related to radiolabeling methods. His work is essential for advancing treatments for B cell lymphoma tumors.
Latest Patents
Morena holds a patent for a radiolabeling method that includes antibody binding assays and radiolabeling kits. This patent is designed for radiolabeling and testing therapeutic antibodies in commercial settings. The kits specifically facilitate the creation and evaluation of radiolabeled anti-CD20 conjugates, which are crucial for the treatment and imaging of B cell lymphoma tumors. All reagents in the kits are sterile, ensuring a high level of antibody radiolabeling and product stability, with results that are highly reproducible. He has 1 patent to his name.
Career Highlights
Ronald A Morena is currently associated with Rit Oncology, LLC, where he continues to develop innovative solutions in oncology. His expertise in radiolabeling methods has positioned him as a valuable asset in the field of cancer research and treatment.
Collaborations
Morena has worked alongside notable colleagues such as Paul Chinn and Michael J LaBarre. Their collaborative efforts contribute to the advancement of therapeutic techniques in oncology.
Conclusion
In summary, Ronald A Morena's contributions to the field of therapeutic antibodies through his innovative patent have significant implications for the treatment of B cell lymphoma tumors. His work exemplifies the importance of innovation in medical research and treatment.